The Nomination Remuneration Committee of the Company, in its meeting held on 07.05.2026, granted and vested options along with the approving changes in the structure of Senior Management ....
CCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CCL Products' Nomination and Remuneration Committee granted 1,61,850 stock options and vested 1,48,473 options to eligible employees under the CCL Employee Stock Option Scheme-2022. The exercise price is Rs. 2 per share (face value), with a 2-year exercise window from vesting date. Additionally, 6,475 options lapsed due to employee resignations. The committee also approved redefinition and reclassification of Senior Management Personnel to align with the current organizational structure. The revised Senior Management team includes CEO Praveen Jaipuriar, CFO Chaitanya Agasthyaraju, and four other key executives.
ESOP grants and vesting can be positive for employee retention and align interests with shareholders, but the lapse of 6,475 options indicates some talent outflow. The restructuring of senior management roles appears administrative rather than a response to leadership changes.